Team

Scott Davidson

Scott Davidson


Vice President, Corporate Strategy & Venture Capital
Scott joined Boston Scientific Ventures in 2016 after serving for over a decade as a Managing Director at a healthcare investment firm, where he focused primarily on investing in small and emerging medical device companies. Earlier in his career, Scott served as a senior equity research analyst at several well-known investment banks covering large and small cap medical device companies, as well as at a large venture capital firm. Scott received his undergraduate degree from Harvard and his MBA from Stanford.
Colin Morrison

Colin Morrison


Director, Business Development & Venture Capital Investments
Colin joined Boston Scientific Ventures in 2019. Prior to joining the venture team, Colin led the development and execution of mergers, acquisitions and venture stage investment strategy for the Urology and Pelvic Health division at Boston Scientific. He previously held multiple roles in the company’s new business development function with a focus on integration and strategic direction, and began his 20+ year career at Boston Scientific in a progression of leadership roles in sales and marketing.
Mary Byron

Mary Byron


Senior Manager, Business Development, Venture Capital
Mary joined Boston Scientific Ventures in 2017. Prior to joining the venture team, Mary led numerous Boston Scientific teams through the development and commercialization of new electrophysiology products. She previously held roles in the company’s operations organization, with a focus on vertical integration. Mary received her undergraduate degree from Iowa State University and her MBA from the University of Minnesota’s Carlson School of Management.
Top